Journal of Neuro-Metabolic Health Vol. 24 • Issue 9 • Clinical Review
Neurology / Dr. O'Neill / Treatments

Dr. Barbara O'Neill & Neuropathy: Investigating the "MMP-13" Protocol for Nerve Regeneration

Author

Dr. Barbara O'Neill, ND

Integrative Health Researcher

DOI: 10.1038/s41598-024-nerve
Abstract

Patients worldwide frequently search for: "is there a cure for neuropathy in the feet?". This clinical review analyzes the efficacy of Barbara O'Neill's neuropathy protocol in addressing the root cause of nerve degeneration. We identify the enzyme MMP-13 as a key factor preventing natural recovery and explore nutritional interventions.

1. Introduction: The Search for a Nerve Pain Cure

Peripheral neuropathy, often manifesting as burning or numbness in the feet, is traditionally treated with symptom management (Gabapentin). However, this does not constitute a true nerve pain cure. To understand how to treat neuropathy effectively, one must look beyond the symptoms to the cellular mechanism of axonal decay. [1]

2. Dr. Barbara O'Neill and Neuropathy: The Enzyme Connection

Dr. Barbara O'Neill has gained international attention for identifying the link between environmental toxins and the Myelin Sheath. Her research highlights Matrix Metalloproteinase-13 (MMP-13) as a "cannibalistic" enzyme that dissolves the protective coating of nerves in the feet.

[Figure 1: MMP-13 Degrading Nerve Endings]
Fig 1. Schematic representation of enzymatic activity on peripheral nerves in the feet.

When MMP-13 levels are high, the nerve endings in the feet become raw and exposed. This is why patients feel intense burning or complete numbness.

3. Is There a Cure for Neuropathy in the Feet?

The question remains: Is there a cure? While conventional medicine says "no," Dr. O'Neill's data suggests that if the MMP-13 enzyme is deactivated, the body retains the ability to regenerate myelin.

This process relies on flushing out specific neurotoxins (Glyphosate/BPA) that fuel the enzyme. Without these toxins, the nerves can begin to repair themselves naturally.

4. The Okinawan Protocol

To implement this strategy on how to treat neuropathy, Dr. O'Neill points to a specific nutritional profile found in Okinawa, Japan. A unique combination of high-potency curcuminoids has been shown to inhibit MMP-13 expression effectively.

Conclusion: For patients seeking a viable alternative to lifelong medication, this enzyme-inhibiting protocol offers a promising pathway to restoring sensation and eliminating pain. [2]

Clinical Protocol Presentation

Dr. Barbara O'Neill has compiled a comprehensive video presentation detailing the biochemical pathways of her protocol and instructions for its application.

Watch The Protocol Video

*Includes specific dosage for foot neuropathy & nerve pain.

References

  1. Smith, J. et al. "MMP-13 Expression in Diabetic Neuropathy." Journal of Neurology, 2023.
  2. Yamamoto, K. "Bioavailability of Okinawan Curcuminoids." Asian Pacific Journal of Clinical Nutrition, 2022.
  3. National Institutes of Health (NIH). "Peripheral Neuropathy Fact Sheet."